258532-83-1

Basic information

• Product Name: 8-acetoxy-4-(2-(1,1-diphenylethoxy)ethyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine
• Synonyms: 8-acetoxy-4-(2-(1,1-diphenylethoxy)ethyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine
• CAS NO: 258532-83-1
• Molecular Weight: 431.488
• Mol File: 258532-83-1.mol

Chemical Properties

• CAS DataBase Reference: 8-acetoxy-4-(2-(1,1-diphenylethoxy)ethyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine(CAS DataBase Reference)
• NIST Chemistry Reference: 8-acetoxy-4-(2-(1,1-diphenylethoxy)ethyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine(258532-83-1)
• EPA Substance Registry System: 8-acetoxy-4-(2-(1,1-diphenylethoxy)ethyl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine(258532-83-1)

Safety Data

• Hazardous Substances Data: 258532-83-1(Hazardous Substances Data)

Upstream product

• 258532-81-9 8-acetoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine 
• 6193-82-4 2-(1,1-diphenylethoxy)ethanol 
• 133-59-5 Toluene-2-sulfonyl chloride 
• 258532-76-2 8-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine 
• 881830-16-6 2-(1,1-diphenylethoxy)ethyl tosylate 

Downstream Products

• 881830-05-3 acetic acid 4-[2-(1,1-diphenyl-ethoxy)-ethyl]-3,4-dihydro-2H-benzo[1,4]oxazin-8-yl ester 
• 258532-88-6 4-(2-(1,1-diphenylethoxy)ethyl)-8-hydroxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine 
• 258532-36-4 methyl (4-(2-(1,1-diphenylethoxy)ethyl)-3,4-dihydro-2H-1,4-benzoxazin-8-yloxy)acetate 

Relevant articles and documents

Development of 3,4-dihydro-2H-benzo[1,4]oxazine derivatives as dual thromboxane A2 receptor antagonists and prostacyclin receptor agonists

We discovered a novel series of 3,4-dihydro-2H-benzo[1,4]oxazin-8- yloxyacetic acid derivatives as potent dual-acting agents to block the TXA 2 receptor and to activate the PGI2 receptor. We report the synthesis, structure-activity r

Benzene fused heterocyclic derivatives having thromboxane A2 receptor antagonistic activity and prostaglandin I2 Agonistic activity and application thereof

Benzene fused derivatives represented by the following formula: having strong TXA2receptor antagonistic action and PGI2receptor agonistic action, and effective for treating or preventing diseases concerning TXA2.